TABLE 3.
Variant 3: Initial treatment of a 60-year-old female without significant past medical history, with uT3N0 rectal cancer, bilobar hepatic metastases (50% liver replacement), and bilateral pulmonary metastases. Rectal lesion causing pain and early symptoms of obstruction. KPS 80
| Treatment | Rating* | Comments |
|---|---|---|
|
| ||
| Initial preoperative pelvic RT + concurrent 5-FU based chemotherapy | 7 | |
| Initial systemic 5-FU-based chemotherapy (FOLFOX/FOLFIRI) | 6 | Consider anti-EGFR agents with FOLFOX/FOLFIRI in wild-type KRAS tumors |
| Initial palliative stent or loop colostomy to relieve obstruction | 5 | |
| Initial systemic 5-FU-based chemotherapy (FOLFOX/FOLFIRI + bevacizumab) | 4 | |
| Initial resection of rectal primary | 3 | |
| Initial pelvic RT alone | 2 | |
| Initial surgical debulking of metastatic disease | 1 | |
| Initial liver directed therapies (transarterial embolization, radiation, RFA) | 1 | |
| Best supportive care | 1 | |
Rating scale: 1–3, usually not appropriate; 4–6, may be appropriate; 7–9, usually appropriate.